The purpose of this study is to find out if the study drug (Sunphenon® 90D, which contains green tea catechins) can help prevent progression of prostate cancer from a low risk stage to higher risk stages in men who are on active surveillance.
Learn more about the EA8184 trial or call the Reading Hospital Cancer Research Office at 484-628-8193.
